WGS insider trading
NasdaqGS HealthcareGeneDx Holdings Corp.: insider trade history from SEC Form 4 filings.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Company website: www.genedx.com
WGS insider activity at a glance
FilingIQ tracks 611 insider transactions for WGS in filings since Jan 23, 2023. The most recent transaction is dated Sep 17, 2026.
Across the full history, 57 open-market purchases
and 354 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on WGS insider trades is 56.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest WGS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for WGS?
- FilingIQ tracks 611 Form 4 insider transactions for WGS (GeneDx Holdings Corp.), covering filings from Jan 23, 2023 onwards. 19 of those are dated within the last 90 days.
- Are WGS insiders net buyers or net sellers?
- Across the full Form 4 history for WGS, 57 transactions (9%) were open-market purchases and 354 (58%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does WGS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is WGS in?
- GeneDx Holdings Corp. (WGS) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $1.94B.
Methodology & sources
Every WGS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.